CompletedPhase 3NCT00233324
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NICHD Neonatal Research Network
- Principal Investigator
- Abbot R. Laptook, MDBrown University, Women & Infants Hospital of Rhode Island
- Intervention
- Surfactant(drug)
- Enrollment
- 1316 enrolled
- Eligibility
- All sexes
- Timeline
- 2005 – 2016
Study locations (22)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Stanford University, Palo Alto, California, United States
- University of California at San Diego, San Diego, California, United States
- Yale University, New Haven, Connecticut, United States
- University of Miami, Miami, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Indiana University, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Wayne State University, Detroit, Michigan, United States
- University of New Mexico, Albuquerque, New Mexico, United States
- University of Rochester, Rochester, New York, United States
- Wake Forest University, Charlotte, North Carolina, United States
- RTI International, Durham, North Carolina, United States
- Duke University, Durham, North Carolina, United States
- +7 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · National Center for Research Resources (NCRR) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00233324 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants